Summit Therapeutics (SUMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 23.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 32.50
  • 52 Week Low: 17.50
  • Currency: UK Pounds
  • Shares Issued: 160.49m
  • Volume: 863
  • Market Cap: 38.12m
  • RiskGrade: 284
  • Beta: 0.35

SUMM Overview

Summit Therapeutics is in the pharma and biotech sector and is currently trading at 23.75p per share. In the last year Summit Therapeutics 's share price has ranged from 17.50p to 32.50p.

1 Day Chart (14-11-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 6.2% n/a
ROCE 7.9%  
Latest F'cast
P/E 2.6 n/a
PEG n/a n/a
Pr/Revenue 0.9 n/a
Pr/Book 0.9  
Latest F'cast
Revenue 69.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SUMM Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-15 1.17 (12.66) (29.00)p n/a n/a n/a n/a 0.0%
31-Jan-16 n/a (23.20) (34.00)p n/a n/a n/a n/a 0.0%
31-Jan-17 2.30 (25.71) (35.00)p n/a n/a n/a n/a 0.0%
31-Jan-18 25.42 (10.89) (11.00)p n/a n/a n/a n/a 0.0%
31-Jan-19 43.01 5.03 9.00p 2.4 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SUMM Company Announcements

Summit Therapeutics to Participate in Panel Sess... 06-Nov-2019 12:00 GlobeNewswire NA
Summit Therapeutics Recognises C. difficile... 04-Nov-2019 12:00 GlobeNewswire NA
Summit Therapeutics to Present at the 2019 BIO I... 16-Oct-2019 12:00 GlobeNewswire NA

Latest SUMM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SUMM Market Data

Currency UK Pounds
Share Price 23.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 32.50
52 Week Low 17.50
Volume 863
Shares Issued 160.49m
Market Cap 38.12m
Beta 0.35
RiskGrade 284

SUMM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.53% above the market average76.53% above the market average76.53% above the market average76.53% above the market average76.53% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average
Price Trend
44.29% below the market average44.29% below the market average44.29% below the market average44.29% below the market average44.29% below the market average
22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average
Income Not Available
Growth
42.77% above the market average42.77% above the market average42.77% above the market average42.77% above the market average42.77% above the market average
62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average

SUMM Dividends

No dividends found

Trades for 14-Nov-2019

Time Volume / Share Price
10:25 863 @ 22.63p

SUMM Key Personnel

CEO Glyn Edwards

Top of Page